SELLAS Life Sciences Group Inc (NASDAQ:SLS)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - SLS
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - SLS
- Market Cap$84.600m
- SymbolNASDAQ:SLS
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS81642T2096
Company Profile
SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S, Nelipepimut-S, GALE-301/-302 and NeuVax.SELLAS Life Sciences Group Inc is a biopharmaceutical company. The company is engaged in the development of novel cancer immunotherapies for a broad range of cancer indications. Its pipeline products are Galinpepimut-S and NeuVax.
Latest SLS news
Currently there for this company. Visit our news hub for other news .